Umeda et al have shown that UBTF-TD expression in CD34 + cells was sufficient to induce a proliferative advantage, increases clonogenic activity and activates the HOXB gene cluster, recapitulating the transcriptional signature observed in UBTF-TD AML patients [13]. Here, CD34 is linked to acute myeloid leukemia.